Acuitas Lipid III-2|Ionizable Lipid for LNP

Cas No.:	2036272-95-2
Chemical Name:	Acuitas Lipid III-2
Synonyms:	Acuitas Lipid III 2，Lipid III2
SMILES:	O=C(OCCCCCCN(CCCCCCOC(C(CCCCCC)CCCCCCCC)=O)CCCO)C(CCCCCC)CCCCCCCC
Formula:	C₄₇H₉₄N₂O₄
M.Wt:	751.3
Purity:	ELSD-HPLC>95%
Sotrage:	1 year -20°C

Cat. No.	Product name	Field of application
DC65412	Acuitas Lipid III-2	Acuitas Lipid III-2 is an ionizable amine lipid with two identical ester tails adjacent to C6 position relative to amine from patent:WO2017075531A1 with the similar activity as ALC-0315. The head of lipid is propanolamine which can effectively encapsulate mRNA used in gene therapies which depends on the availability of a safe and efficient delivery vehicle.
DC67217	Moderna Lipid 48	Moderna Lipid 48 is an novel ionizable amine lipid used for mRNA delivery from Moderna patent WO2017049245A2
DC67212	Acuitas Lipid III-25	Acuitas Lipid III-25 is an novel ionizable amine lipid used for mRNA delivery from Acuitas Therapeutics patent US 10,166,298 B2, with pKa 6.22, Liver Luc 1648 for 0.3mgkg(ng luc/g liver), Liver Luc 13880 for 1mgkg(ng luc/g liver) . It is an analgous of ALC-0315, showing higher activity than ALC-0315.
DC65701	L-369	L-369 (Lipid 369,L369) is novel class of ionizable lipid for siRNA delivery with improved in vivo elimination profile with excellent translation across species,including NHP, wide safety margin.